NeoVista Report issue

For profit Phase 3
Founded: Newark CA United States (2002)
Status: Defunct (2017)

Organization Overview

First Clinical Trial
2007
NCT00454389
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Alternative names

NeoVista, Inc.